PTC Therapeutic's Upstaza gene therapy for patients with genetic disorder AADC deficiency has been recommended for approval in the EU, setting up another test of the commercial prospects for gene ...

PTC Industries’ (PTCIL) Q3FY26 EBITDA grew 62% YoY to INR 248mn (-4% YoY) aided by more-than-double sales growth. ATL and TARC registered good top-line growth but margins were under pressure due to ...

Revenue also exceeded forecasts, reaching $894 million compared to the anticipated $750.87 million, marking a 19.06% surprise. Despite these strong earnings, Mizuho has lowered its price target for ...

Seth MacFarlane once famously called the PTC "like getting hate mail from Hitler." Now they've filed for Chapter 11. By James Hibberd Writer-at-Large The organization’s tagline was “Because Our ...

BOSTON, June 4, 2025 /PRNewswire/ --PTC (NASDAQ: PTC) today announced the latest version of its Creo ® computer-aided design (CAD) solution, built to help manufacturers deliver their best designs in ...

Janet Sofy serves as CEO of HMS HMS’s products are developed for home storage and organization, waste, laundry, kitchen, and pet categories Creo Group, a portfolio company of Mill Point Capital, has ...

Feb 5 (Reuters) - PTC (PTC.O), opens new tab cut its full-year revenue and adjusted earnings forecasts on Wednesday amid increasing competition and fears over President Donald Trump's tariff policy, ...

Fueled by emerging markets and a growing demand for lightweight-yet-durable materials, the composites industry is a rising economic force. Global demand for composite-based products is growing at an ...

Throughout the last three months, 6 analysts have evaluated PTC (NASDAQ:PTC), offering a diverse set of opinions from bullish to bearish. The following table provides a quick overview of their recent ...

The FDA issued its first stamp of approval for a cell or gene therapy back in 2017 to Novartis' Kymriah. Now, seven years and many approvals later, innovation in the space has hit new heights with PTC ...